194 related articles for article (PubMed ID: 16236044)
1. Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.
Thomsen RW; Johnsen SP; Olesen AV; Mortensen JT; Bøggild H; Olsen J; Sørensen HT
Br J Clin Pharmacol; 2005 Nov; 60(5):534-42. PubMed ID: 16236044
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic correlates of drug use based on prescription data: a population-based cross-sectional register study in Denmark 1999.
Mortensen JT; Olesen AV; Bøggild H; Olsen J; Westergård-Nielsen NC
Dan Med Bull; 2007 Feb; 54(1):62-6. PubMed ID: 17349231
[TBL] [Abstract][Full Text] [Related]
3. Hip fracture risk in statin users--a population-based Danish case-control study.
Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women.
Olesen AV; Johnsen SP; Mortensen JT; Bøggild H; Olsen J; Sørensen HT
Acta Obstet Gynecol Scand; 2005 Jul; 84(7):639-44. PubMed ID: 15954872
[TBL] [Abstract][Full Text] [Related]
5. Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study.
Stocks NP; Ryan P; McElroy H; Allan J
Med J Aust; 2004 Mar; 180(5):229-31. PubMed ID: 14984343
[TBL] [Abstract][Full Text] [Related]
6. Statin prescribing according to gender, age and indication: what about the benefit-risk balance?
Wallach-Kildemoes H; Stovring H; Holme Hansen E; Howse K; Pétursson H
J Eval Clin Pract; 2016 Apr; 22(2):235-46. PubMed ID: 26446680
[TBL] [Abstract][Full Text] [Related]
7. The use of antidepressants and introduction of new types in different socio-economic groups: a Danish registry-based cross-sectional study.
Roer K; Fonager K; Bingley P; Mortensen JT
Nord J Psychiatry; 2010 Aug; 64(4):268-72. PubMed ID: 20100133
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
Byrne P; Cullinan J; Murphy C; Smith SM
BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
[TBL] [Abstract][Full Text] [Related]
9. Equity in statin use in New Zealand.
Norris P; Horsburgh S; Becket G; Keown S; Arroll B; Lovelock K; Crampton P; Cumming J; Herbison P
J Prim Health Care; 2014 Mar; 6(1):17-22. PubMed ID: 24624407
[TBL] [Abstract][Full Text] [Related]
10. A population-based analysis of statin utilization in British Columbia.
Raymond CB; Morgan SG; Katz A; Kozyrskyj AL
Clin Ther; 2007 Sep; 29(9):2107-19. PubMed ID: 18035209
[TBL] [Abstract][Full Text] [Related]
11. Gender, socioeconomic status, need or access? Differences in statin prescribing across urban, rural and remote Australia.
Stocks N; Ryan P; Allan J; Williams S; Willson K
Aust J Rural Health; 2009 Apr; 17(2):92-6. PubMed ID: 19335599
[TBL] [Abstract][Full Text] [Related]
12. Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.
Wallach-Kildemoes H; Diderichsen F; Krasnik A; Lange T; Andersen M
BMC Public Health; 2012 Aug; 12():610. PubMed ID: 22863326
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?
Aarnio E; Martikainen J; Winn AN; Huupponen R; Vahtera J; Korhonen MJ
Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):704-713. PubMed ID: 27756795
[TBL] [Abstract][Full Text] [Related]
14. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
[TBL] [Abstract][Full Text] [Related]
15. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients.
Thomsen RW; Riis A; Kornum JB; Christensen S; Johnsen SP; Sørensen HT
Arch Intern Med; 2008 Oct; 168(19):2081-7. PubMed ID: 18955636
[TBL] [Abstract][Full Text] [Related]
16. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk among statin users: a population-based cohort study.
Friis S; Poulsen AH; Johnsen SP; McLaughlin JK; Fryzek JP; Dalton SO; Sørensen HT; Olsen JH
Int J Cancer; 2005 Apr; 114(4):643-7. PubMed ID: 15578694
[TBL] [Abstract][Full Text] [Related]
18. Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004-2015.
Blais JE; Chan EW; Law SWY; Mok MT; Huang D; Wong ICK; Siu CW
Atherosclerosis; 2019 Jan; 280():174-182. PubMed ID: 30529830
[TBL] [Abstract][Full Text] [Related]
19. Validating registry data on statins prescriptions by blood measurements.
Riis AH; Erichsen R; Ostenfeld EB; Højskov CS; Thorlacius-Ussing O; Stender MT; Lash TL; Møller HJ
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):609-615. PubMed ID: 30779395
[TBL] [Abstract][Full Text] [Related]
20. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
